ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 160 filers reported holding ZIOPHARM ONCOLOGY INC in Q4 2020. The put-call ratio across all filers is 1.51 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $333,000 | -35.3% | 511,120 | +8.2% | 0.00% | – |
| Q4 2021 | $515,000 | -40.1% | 472,320 | 0.0% | 0.00% | -100.0% |
| Q3 2021 | $860,000 | -31.0% | 472,320 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $1,247,000 | -29.3% | 472,320 | -3.5% | 0.00% | 0.0% |
| Q1 2021 | $1,763,000 | +44.0% | 489,620 | +0.8% | 0.00% | 0.0% |
| Q4 2020 | $1,224,000 | 0.0% | 485,620 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $1,224,000 | -19.9% | 485,620 | +4.2% | 0.00% | 0.0% |
| Q2 2020 | $1,529,000 | +54.1% | 466,220 | +15.1% | 0.00% | 0.0% |
| Q1 2020 | $992,000 | -20.6% | 405,020 | +53.1% | 0.00% | 0.0% |
| Q4 2019 | $1,249,000 | +12.7% | 264,520 | +2.2% | 0.00% | 0.0% |
| Q3 2019 | $1,108,000 | -25.4% | 258,920 | +1.6% | 0.00% | -50.0% |
| Q2 2019 | $1,486,000 | +69.1% | 254,820 | +11.7% | 0.00% | +100.0% |
| Q1 2019 | $879,000 | +105.9% | 228,220 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $427,000 | -39.1% | 228,220 | +4.2% | 0.00% | 0.0% |
| Q3 2018 | $701,000 | +6.1% | 218,920 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $661,000 | -23.0% | 218,920 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $858,000 | -5.3% | 218,920 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $906,000 | -32.6% | 218,920 | 0.0% | 0.00% | -50.0% |
| Q3 2017 | $1,344,000 | -1.3% | 218,920 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $1,362,000 | +19.1% | 218,920 | +21.3% | 0.00% | +100.0% |
| Q1 2017 | $1,144,000 | +18.5% | 180,420 | 0.0% | 0.00% | -50.0% |
| Q4 2016 | $965,000 | -5.0% | 180,420 | 0.0% | 0.00% | 0.0% |
| Q3 2016 | $1,016,000 | +2.5% | 180,420 | 0.0% | 0.00% | 0.0% |
| Q2 2016 | $991,000 | -29.1% | 180,420 | -7.4% | 0.00% | -33.3% |
| Q1 2016 | $1,397,000 | +5.6% | 194,920 | +22.4% | 0.00% | 0.0% |
| Q4 2015 | $1,323,000 | -5.7% | 159,220 | +2.2% | 0.00% | -25.0% |
| Q3 2015 | $1,403,000 | -6.9% | 155,720 | +24.0% | 0.00% | 0.0% |
| Q2 2015 | $1,507,000 | +27.1% | 125,620 | +14.1% | 0.00% | +33.3% |
| Q1 2015 | $1,186,000 | +132.1% | 110,100 | +9.2% | 0.00% | +50.0% |
| Q4 2014 | $511,000 | +102.8% | 100,800 | +5.4% | 0.00% | +100.0% |
| Q3 2014 | $252,000 | -34.5% | 95,600 | 0.0% | 0.00% | 0.0% |
| Q2 2014 | $385,000 | -12.1% | 95,600 | 0.0% | 0.00% | -50.0% |
| Q1 2014 | $438,000 | +27.0% | 95,600 | +20.3% | 0.00% | +100.0% |
| Q4 2013 | $345,000 | – | 79,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DISCOVERY CAPITAL MANAGEMENT, LLC / CT | 15,461,829 | $2,037,869 | 0.36% |
| MSD Partners, L.P. | 15,151,516 | $1,996,970 | 0.16% |
| MSD Partners, L.P. | 7,575,758 | $998,485 | 0.08% |
| MAGNOLIA CAPITAL ADVISORS LLC | 865,938 | $65,552 | 0.03% |
| Allred Capital Management, LLC | 253,000 | $33,345 | 0.02% |
| CHIRON CAPITAL MANAGEMENT, LLC | 77,023 | $10,152 | 0.01% |
| Boxer Capital, LLC | 1,100,000 | $144,980 | 0.01% |
| GSA CAPITAL PARTNERS LLP | 569,566 | $75 | 0.01% |
| Sugarloaf Wealth Management, LLC | 75,500 | $9,951 | 0.00% |
| Owen LaRue, LLC | 11,825 | $1,559 | 0.00% |